Adonis

Description

Medicinal Parts

The medicinal part is derived from the aerial parts of the herb, which are collected during the flowering season and dried.

Flower and Fruit

The erect, solitary, terminal flower is 4 to 7 cm in diameter and the 5 broad-ovate, downy sepals are half as long as the petals. The 10 to 20 petals are narrow, wedge-shaped, simple or finely serrated at the tip. They are 20 to 40 mm long and lemon-yellow, splayed, glossy, reddish on the outside or greenish-tinged. There are numerous stamens and carpels. The small fruit forms a globose capitulum. The fruit is tomentose, wrinkled, laterally veined and keeled with a sideways-facing, hook-shaped beak. The fruit are arranged on the spindle-shaped, oblong receptacle.

Leaves, Stem, and Root

The plant is 10 to 40 cm high with a sturdy, black-brown rhizome. The stem is erect, undivided, covered with scales at the base, vertically grooved and succulent. There are few branches. The leaves have many slits and a curved, glabrous or sparsely haired tip. The middle leaves are half-clasping.

Characteristics

Adonis is a poisonous plant.

Habitat

This Siberian/east European plant is found in the north as far as the central Urals and southwest Sweden. In central Europe, it is limited to the basins of the Weichsel and the Oder as far as the Main and Rhine.

Production

The drug is gathered in forests and should be dried quickly.

Not to be Confused With

Other Adonis species may be added to Adonidis herba.

Other Names

False Hellebore, Yellow Pheasant's Eye, Ox-eye, Sweet Vernal, Pheasant's Eye, Red Morocco, Rose-a-Rubie

Actions & Pharmacology

Compounds

Cardioactive steroid gylcosides (cardenolids): including adonitoxin, k-strophanthoside, k-strophanthoside-β and cymarin

Flavonoids: including vitexin and luteolin

Effects

Adonis has a positive inotropic effect. Animal tests demonstrated a tonic effect on the veins. The adonitoxin component is slightly more toxic than coumarin. The drug is insufficiently documented.

Indications & Usage

Approved by Commission E:

  • Arrhythmia
  • Nervous heart complaints

Unproven Uses

The drug is used for mild impairment of heart functions (NYHA I and II), especially when accompanied by nervous symptoms.

In Russian folk medicine, the drug is used for dehydration, cramps, fever and menstrual disorders, but efficacy is unproven.

Homeopathic Uses

Preparations of Adonis vernalis are used for cardiac insufficiency.

Contraindications

Adonis is contraindicated in conjunction with digitalis glycoside therapy and also in potassium deficiency.

Precautions & Adverse Reactions

General

Despite the strong efficacy of the drug's cardioactive steroid gylcosides in parenteral application, serious poisoning in the course of per oral administration is hardly to be expected due to the low resorption rate.

Drug Interactions

Digoxin

Concurrent use is contraindicated.

Overdosage

For possible symptoms of overdose and treatment of poisonings see Digitalis folium.

Dosage

Mode of Administration

Comminuted herb and preparations thereof for internal use.

Daily Dosage

The average daily dose is 0.6 gm of standardized Adonis powder. The maximum single dose is 1.0 gm; maximum daily dose is 3.0 gm.

Homeopathic Dosage

From D2: 5 to 10 drops, 1 tablet or 5 to 10 globules, 1 to 3 times daily; Injection solution: 1 ml once a week sc. From D4: Injection solution: 1 ml twice weekly sc.

Storage

Adonis herb and powder should be stored carefully. Adonis powder should be stored away from light in tightly sealed containers.

Literature

Brevoort P, Der Heilpflanzenmarkt der USA - Ein überblick. In: ZPT 18(3):155-162. 1997.ESCOP-Monographs. In: ESCOP-Monographs Fascicule I and II. 1996.Hiller KO, Rahlfs V, Therapeutische äquivalenz eines hochdosierten Phytopharmakons mit Amytriptylin bei ängstlich-depressiven Versimmungen - Reanalyse einer randomisierten Studie unter besonderer Beachtung biometrischer und klinischer Aspekte. In: Forsch.Lee MK, et al., Antihepatotoxic activity of Icariin, a major constituent of Epimedium koreanum. In: PM 61(6):523-526. 1995.Loew, Buch. In: Loew D, Rietbrock N: Phytopharmaka II: Forschung und klinische Anwendung, Steinkopff Verlag, Darmstadt, 1996.Loew DA, Loew AD, Pharmakokinetik von herzglykosidhaltigen Pflanzenextrakten. In: ZPT 15(4):197-202. 1994.Loew D, Phytotherapie bei Herzinsuffizienz. In: ZPT 18(2):92-96. 1997.Martinez-Vazquez M, Ramirez Apan TO, Hidemi Aguilar M, Bye R, Analgesic and antipyretic activities of an aqueous extract and of the flavone Linarin of Buddleia cordata. In: PM 62:137-140. 1996.Reinhard KH, Uncaria tomentosa (WILLD.) DC. - Cat's claw, Una de gato oder Katzenkralle Protrait einer Arzneipflanze. In: ZPT 18(2):112-121. 1997.Sandberg F, Thorsen R, (1962) Lloydia 25(3):201.Schulz V, Hübner WD, Ploch M, Klinische Studien mit Psycho-Phytopharmaka. In: ZPT 18(3):141-154. 1997.Winkler C and Wichtel M, (1985) Pharm Acta Helv 60(9/10): 234.

This information is an educational aid only. It is not intended as medical advice for individual conditions or treatments.
Talk to your doctor, nurse, or pharmacist before following any medical regimen to see if it is safe and effective for you. Please read this important disclaimer about the information within our guide.

Coenzyme Q1-

Advertisement